• 6 March 2012 – EMA updates guidance on drug/device consultation procedure

• 3 February 2012 – Guidance on EU Authorised Representatives published

• 30 January 2012 – European Commission publishes several new guidance documents

• 19 January 2012 – Revised MEDDEV on post-market clinical follow-up studies published